- Book
- April 2024
- 448 Pages
- Book
- December 2023
- 864 Pages
- Book
- April 2023
- 176 Pages
- Book
- May 2021
- 512 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2020
- 600 Pages
- Book
- November 2019
- 432 Pages
- Book
- October 2019
- 632 Pages
- Book
- January 2019
- 600 Pages
- Book
- April 2018
- 776 Pages
United States
- Book
- August 2015
- 288 Pages
- Book
- April 2013
- 294 Pages
- Book
- April 2012
- 776 Pages
- Book
- November 2011
- 432 Pages
- Book
- November 2010
- 456 Pages
- Book
- October 2010
- 454 Pages
- Book
- September 2010
- 448 Pages
- Book
- October 2023
North America

Leukemia is a type of cancer that affects the blood and bone marrow. It is a form of hematological malignancy, which is a cancer of the blood-forming cells. Leukemia is characterized by an abnormal increase in the number of white blood cells in the body, which can interfere with the normal functioning of the blood and bone marrow. Symptoms of leukemia can include fatigue, fever, anemia, and an enlarged spleen. Treatment for leukemia typically involves chemotherapy, radiation therapy, and/or stem cell transplantation.
There are several companies that are involved in the Leukemia market. These include pharmaceutical companies such as Novartis, Celgene, and Bristol-Myers Squibb, as well as biotechnology companies such as Gilead Sciences and Amgen. Additionally, there are a number of research organizations and academic institutions that are actively researching new treatments for leukemia. Show Less Read more